If the perforin-granzyme system has been shown to play a major role in tumor cell elimination, as demonstrated by the development of spontaneous B cell lymphomas in the perforin-deficient mice, FasL expressed on CTL is a second way used by lymphocytes to kill cancer cells (Figure 2). Here, PRF1 is linked to cancer.